Please use this identifier to cite or link to this item: http://localhost:80/xmlui/handle/123456789/14219
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSUBRAMANIAN, S-
dc.contributor.authorSANKAR, V-
dc.contributor.authorMANAKADAN, ASHA ASOKAN-
dc.contributor.authorISMAIL, SAREENA-
dc.contributor.authorANDHUVAN, G-
dc.date.accessioned2022-11-29T06:45:28Z-
dc.date.available2022-11-29T06:45:28Z-
dc.date.issued2010-04-19-
dc.identifier.citationSubramanian, S., Sankar, V., Manakadan, A. A., Ismail, S., & Andhuvan, G. (2010). Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet. Pakistan journal of pharmaceutical sciences, 23(2), 232-236.en_US
dc.identifier.issn1011-601X-
dc.identifier.urihttp://142.54.178.187:9060/xmlui/handle/123456789/14219-
dc.description.abstractCetirizine orodispersible tablets were prepared to achieve quick onset of action and for maximum bioavailability. Tablets were prepared using cetirizine along with camphor and mannitol in the proportion of 1:1:1, 1:1:3, and 1:1:6. The flow property of granules was found to be good for the formulation CZ2 (1:1:3). The hardness and friability of all the formulations were found to be within the standard limit for orodispersible tablets. Disintegration time was found to be rapid in formulation CZ2 (1:1:3).The in vitro dissolution time was found to be 100% in 11 minutes for the formulation CZ2 (1:1:3).en_US
dc.language.isoenen_US
dc.publisherKarachi: Faculty of Pharmacy & Pharmaceutical Sciences, Karachien_US
dc.subjectCetirizine orodispersible tabletsen_US
dc.subjectHPLC methoden_US
dc.subjecthausner ratioen_US
dc.subjectwetting timeen_US
dc.titleFORMULATION AND EVALUATION OF CETIRIZINE DIHYDROCHLORIDE ORODISPERSIBLE TABLETen_US
dc.typeArticleen_US
Appears in Collections:Issue 02

Files in This Item:
File Description SizeFormat 
Paper-19.htm143 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.